Inhibikase Therapeutics Inc (IKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IKT | CNTX | RCEL | ||
| Company | Inhibikase Therapeutics Inc | Context Therapeutics Inc | Avita Medical Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.6600 | 1.4900 | 3.47 | ||
| High | 1.7200 | 1.5200 | 3.94 | ||
| Low | 1.6300 | 1.4200 | 3.47 | ||
| Latest | 1.6700 | 1.4400 | 3.90 | ||
| Change | +0.0200 | -0.0800 | +0.44 | ||
| % Change | +1.21% | -5.26% | +12.72% | ||
| Volume | 319,000 | 1,116,700 | 318,200 | ||
| 20-Day Average Volume | 647,495 | 1,619,005 | 231,120 | ||
| Previous Close | 1.6500 | 1.5200 | 3.46 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.7958 | 1.4065 | 3.45 | ||
| 20-Day Raw Stochastic | 18.36% | 39.46% | 94.44% | ||
| 20-Day Relative Strength | 48.64 | 55.80 | 58.78 | ||
| Weighted Alpha | -33.56 | +10.94 | -54.61 | ||
| Today's Opinion | 8% Buy | 100% Buy | 64% Sell | ||
| Previous Opinion | 8% Buy | 100% Buy | 88% Sell | ||
| Last Month's Opinion | 64% Sell | 56% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.62% since 01/09/26 | -10.56% since 01/09/26 | +14.71% since 01/09/26 | ||
| Low | 1.6300 on 01/16/26 | 1.4200 on 01/16/26 | 3.24 on 01/13/26 | ||
| High | 1.7267 on 01/13/26 | 1.6500 on 01/14/26 | 3.94 on 01/16/26 | ||
| 1-Month | |||||
| %Chg | +4.37% since 12/16/25 | +30.91% since 12/16/25 | +17.12% since 12/16/25 | ||
| Low | 1.5500 on 12/17/25 | 1.0650 on 12/17/25 | 3.22 on 01/07/26 | ||
| High | 2.1591 on 01/05/26 | 2.0000 on 01/05/26 | 3.94 on 01/16/26 | ||
| 3-Month | |||||
| %Chg | +10.60% since 10/16/25 | +14.29% since 10/16/25 | -27.51% since 10/16/25 | ||
| Low | 1.3300 on 11/03/25 | 0.9949 on 12/10/25 | 3.22 on 01/07/26 | ||
| High | 2.1591 on 01/05/26 | 2.0000 on 01/05/26 | 4.55 on 10/17/25 | ||
| 6-Month | |||||
| %Chg | -10.22% since 07/16/25 | +74.50% since 07/16/25 | -26.83% since 07/16/25 | ||
| Low | 1.3300 on 11/03/25 | 0.6752 on 08/04/25 | 3.22 on 01/07/26 | ||
| High | 2.1591 on 01/05/26 | 2.0000 on 01/05/26 | 7.12 on 09/15/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 125,542 | 132,306 | 118,923 | ||
| Shares Outstanding, K | 75,175 | 91,879 | 30,493 | ||
| Annual Sales | 0 | 0 | 64,250,000 | ||
| Annual Net Income | -27,520,000 | -26,730,000 | -61,850,000 | ||
| Last Quarter Sales | 0 | 0 | 17,060,000 | ||
| Last Quarter Net Income | -11,930,000 | -9,690,000 | -13,190,000 | ||
| 60-Month Beta | 0.84 | 1.91 | 1.70 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.13 on 11/14/25 | -0.10 on 11/05/25 | -0.46 on 11/06/25 | ||
| Latest Earnings Date | 03/26/26 | 03/19/26 | 02/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||